Disambiguation evidence for Rituxan via surface form

"rituximab"

Triples (15)

Triples where some other subject referred to this entity as "rituximab".

Rituxan → hasINN →
"rituximab"
↳ resolves to Rituxan
ⓘ
non-Hodgkin lymphoma → hasCommonDrug →
"rituximab"
↳ resolves to Rituxan
ⓘ
Wegener's granulomatosis → treatedWith →
"rituximab"
↳ resolves to Rituxan
ⓘ
MabThera → hasInternationalNonproprietaryName →
"rituximab"
↳ resolves to Rituxan
ⓘ
CD20 protein → targetOf →
"rituximab"
↳ resolves to Rituxan
ⓘ
B lymphocytes → targetOf →
"rituximab"
↳ resolves to Rituxan
ⓘ
R-CHOP → includesDrug →
"rituximab"
↳ resolves to Rituxan
ⓘ
R-CHOP → containsMonoclonalAntibody →
"rituximab"
↳ resolves to Rituxan
ⓘ
Ruxience → hasINN →
"rituximab"
↳ resolves to Rituxan
ⓘ
Riabni → isBiosimilarTo →
"rituximab"
↳ resolves to Rituxan
ⓘ
GPA → treatedWith →
"rituximab"
↳ resolves to Rituxan
ⓘ
MabThera SC → hasActiveIngredient →
"rituximab"
↳ resolves to Rituxan
ⓘ
linked to: MabThera SC for subcutaneous formulation
MabThera SC → isFormulationOf →
"rituximab"
↳ resolves to Rituxan
ⓘ
linked to: MabThera SC for subcutaneous formulation
MS4A1 → targetOfDrug →
"rituximab"
↳ resolves to Rituxan
ⓘ
linked to: MS4A1 gene
microscopic polyangiitis → treatedWith →
"rituximab"
↳ resolves to Rituxan
ⓘ